Cosentyx unoready 300 MG pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FM7F7
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $19,811
Award facts
- Contract value 100% obligated
- $19,810.54 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $19,810.54 to AmerisourceBergen Drug Corp for the supply of Cosentyx (secukinumab) 300 mg pen auto-injectors (2 mL) on December 17, 2025, with completion scheduled for December 18, 2025. This competitively awarded, firm fixed-price delivery order was executed without set-aside provisions and will be performed at the vendor's corporate office in Conshohocken, Pennsylvania. Cosentyx is a biologic medication used to treat inflammatory conditions including psoriasis, psoriatic arthritis, and ankylosing spondylitis, supporting the Defense Health Agency's pharmaceutical supply requirements for military beneficiaries.
This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999, which extends through December 2026. As a prime pharmaceutical vendor, AmerisourceBergen Drug Corp supplies a comprehensive range of medications and medical supplies to support military healthcare systems globally. The company's status as a major pharmaceutical distributor and its competitive track record on federal contracts demonstrate its capability to fulfill specialized medical procurement requirements efficiently for Department of Defense healthcare operations.
Quick answers
Who was awarded contract SPE2DR26FM7F7?
SPE2DR26FM7F7 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 17, 2025.
How much is contract SPE2DR26FM7F7 worth?
The government has obligated $19,811 on SPE2DR26FM7F7.
Is contract SPE2DR26FM7F7 an order under another contract?
Yes. SPE2DR26FM7F7 is a delivery order under SPE2DR25D2211, an indefinite delivery contract.
Was contract SPE2DR26FM7F7 competed?
The extent of competition for SPE2DR26FM7F7 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award